Timossi C M, Barrios de Tomasi J, Zambrano E, González R, Ulloa-Aguirre A
Department of Pharmacology, Faculty of Medicine, Universidad Nacional Autónoma de México, México, DF.
Neuroendocrinology. 1998 Mar;67(3):153-63. doi: 10.1159/000054310.
It is well known that deglycosylation of gonadotropins by enzymatic or chemical procedures or by deletion of sites for N-linked glycosylation produces antagonistic analogs which are able to interact strongly with the receptor and to inhibit binding of the wild-type hormone. In the present study, we analyzed the antagonistic properties of a naturally occurring basic follicle-stimulating hormone (FSH) charge isoform obtained after high-resolution chromatofocusing of human anterior pituitary glycoprotein extracts. Coincubation of increasing amounts of this isoform with a highly purified human pituitary FSH preparation or with recombinant human FSH at doses equivalent to their corresponding ED50 for estradiol and tissue-type plasminogen activator (tPA) production, inhibited FSH-induced estrogen production and tPA enzyme activity by cultured rat granulosa cells in a dose-dependent manner. These inhibitory effects were apparently exerted at steps following 3',5'-cyclic adenosine monophosphate (cAMP) formation and did not involve activation of the protein kinase C pathway since: (a) at low doses, this basic FSH isoform moderately increased FSH-induced cAMP production by cultured rat granulosa cells; (b) coincubation of the antagonist isoform with dibutyryl cAMP completely inhibited the effects of this cAMP analog on estrogen and tPA production; (c) the isoform was able to stimulate production of cAMP in a human fetal cell line expressing the recombinant human FSH receptor, and (d) the inhibitory effects of the isoform were not affected by staurosporine, a protein kinase C inhibitor. The effects of this isoform upon dibutyryl cAMP-induced estrogen and tPA production were blocked by the addition of a highly specific antibody directed against human FSH, further demonstrating that the antagonistic effects observed were due to FSH-like molecules. In contrast to the inhibitory effects exhibited by this basic FSH isoform, a more acidic FSH charge variant consistently acted as an agonist of pituitary and recombinant FSH on both estrogen production and induction of tPA enzyme activity. These results indicate that the anterior pituitary gland normally produces FSH isoforms which act as either agonists or antagonists of FSH at the target cell level.
众所周知,通过酶法、化学方法或缺失N - 糖基化位点对促性腺激素进行去糖基化会产生拮抗类似物,这些拮抗类似物能够与受体强烈相互作用并抑制野生型激素的结合。在本研究中,我们分析了通过对人垂体前叶糖蛋白提取物进行高分辨率色谱聚焦获得的一种天然存在的碱性卵泡刺激素(FSH)电荷异构体的拮抗特性。将该异构体的量逐渐增加,与高度纯化的人垂体FSH制剂或重组人FSH共同孵育,剂量相当于它们对雌二醇和组织型纤溶酶原激活剂(tPA)产生的相应半数有效剂量(ED50),以剂量依赖的方式抑制培养的大鼠颗粒细胞中FSH诱导的雌激素产生和tPA酶活性。这些抑制作用显然是在3',5'-环磷酸腺苷(cAMP)形成后的步骤中发挥的,并且不涉及蛋白激酶C途径的激活,因为:(a)在低剂量下,这种碱性FSH异构体适度增加培养的大鼠颗粒细胞中FSH诱导的cAMP产生;(b)拮抗剂异构体与二丁酰cAMP共同孵育完全抑制了这种cAMP类似物对雌激素和tPA产生的影响;(c)该异构体能够在表达重组人FSH受体的人胎儿细胞系中刺激cAMP的产生,并且(d)该异构体的抑制作用不受蛋白激酶C抑制剂星形孢菌素的影响。通过添加针对人FSH的高度特异性抗体,可阻断该异构体对二丁酰cAMP诱导的雌激素和tPA产生的影响,进一步证明观察到的拮抗作用是由于FSH样分子引起的。与这种碱性FSH异构体表现出的抑制作用相反,一种酸性更强的FSH电荷变体在雌激素产生和tPA酶活性诱导方面始终作为垂体FSH和重组FSH的激动剂起作用。这些结果表明,垂体前叶通常产生FSH异构体,它们在靶细胞水平上作为FSH的激动剂或拮抗剂起作用。